On The Pen With Dave Knapp Podcast Por Dave Knapp Man On The Mounjaro Bleav arte de portada

On The Pen With Dave Knapp

On The Pen With Dave Knapp

De: Dave Knapp Man On The Mounjaro Bleav
Escúchala gratis

Acerca de esta escucha

 Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!© 2025 On The Pen With Dave Knapp Enfermedades Físicas Hygiene & Healthy Living Política y Gobierno
Episodios
  • GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25

    GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25
    Jun 10 2025
    https://www.linktr.ee/manonthemounjaro Ozempic rare eye disease update The the race for once monthly dosing Big insurance wins incoming?!
    Más Menos
    23 m
  • Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens

    Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens
    Jun 3 2025

    VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro
    JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM
    Más Menos
    21 m
  • Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?

    Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?
    May 20 2025

    Join the Substack here: onthepen.substack.com
    Get all my links here: https://linktr.ee/manonthemounjaro
    Más Menos
    30 m
adbl_web_global_use_to_activate_webcro805_stickypopup
Todas las estrellas
Más relevante  
This is my go to info on how to handle dr’s, updated meds info, compounding, and how to talk about obesity as a disease. Love it!

Great for all the latest updates

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.